Literature DB >> 24901545

2-tier in-plane motion correction and out-of-plane motion filtering for contrast-enhanced ultrasound.

Casey N Ta1, Mohammad Eghtedari, Robert F Mattrey, Yuko Kono, Andrew C Kummel.   

Abstract

OBJECTIVES: Contrast-enhanced ultrasound (CEUS) cines of focal liver lesions (FLLs) can be quantitatively analyzed to measure tumor perfusion on a pixel-by-pixel basis for diagnostic indication. However, CEUS cines acquired freehand and during free breathing cause nonuniform in-plane and out-of-plane motion from frame to frame. These motions create fluctuations in the time-intensity curves (TICs), reducing the accuracy of quantitative measurements. Out-of-plane motion cannot be corrected by image registration in 2-dimensional CEUS and degrades the quality of in-plane motion correction (IPMC). A 2-tier IPMC strategy and adaptive out-of-plane motion filter (OPMF) are proposed to provide a stable correction of nonuniform motion to reduce the impact of motion on quantitative analyses.
MATERIALS AND METHODS: A total of 22 cines of FLLs were imaged with dual B-mode and contrast specific imaging to acquire a 3-minute TIC. B-mode images were analyzed for motion, and the motion correction was applied to both B-mode and contrast images. For IPMC, the main reference frame was automatically selected for each cine, and subreference frames were selected in each respiratory cycle and sequentially registered toward the main reference frame. All other frames were sequentially registered toward the local subreference frame. Four OPMFs were developed and tested: subsample normalized correlation (NC), subsample sum of absolute differences, mean frame NC, and histogram. The frames that were most dissimilar to the OPMF reference frame using 1 of the 4 above criteria in each respiratory cycle were adaptively removed by thresholding against the low-pass filter of the similarity curve. Out-of-plane motion filter was quantitatively evaluated by an out-of-plane motion metric (OPMM) that measured normalized variance in the high-pass filtered TIC within the tumor region-of-interest with low OPMM being the goal. Results for IPMC and OPMF were qualitatively evaluated by 2 blinded observers who ranked the motion in the cines before and after various combinations of motion correction steps.
RESULTS: Quantitative measurements showed that 2-tier IPMC and OPMF improved imaging stability. With IPMC, the NC B-mode metric increased from 0.504 ± 0.149 to 0.585 ± 0.145 over all cines (P < 0.001). Two-tier IPMC also produced better fits on the contrast-specific TIC than industry standard IPMC techniques did (P < 0.02). In-plane motion correction and OPMF were shown to improve goodness of fit for pixel-by-pixel analysis (P < 0.001). Out-of-plane motion filter reduced variance in the contrast-specific signal as shown by a median decrease of 49.8% in the OPMM. Two-tier IPMC and OPMF were also shown to qualitatively reduce motion. Observers consistently ranked cines with IPMC higher than the same cine before IPMC (P < 0.001) as well as ranked cines with OPMF higher than when they were uncorrected.
CONCLUSION: The 2-tier sequential IPMC and adaptive OPMF significantly reduced motion in 3-minute CEUS cines of FLLs, thereby overcoming the challenges of drift and irregular breathing motion in long cines. The 2-tier IPMC strategy provided stable motion correction tolerant of out-of-plane motion throughout the cine by sequentially registering subreference frames that bypassed the motion cycles, thereby overcoming the lack of a nearly stationary reference point in long cines. Out-of-plane motion filter reduced apparent motion by adaptively removing frames imaged off-plane from the automatically selected OPMF reference frame, thereby tolerating nonuniform breathing motion. Selection of the best OPMF by minimizing OPMM effectively reduced motion under a wide variety of motion patterns applicable to clinical CEUS. These semiautomated processes only required user input for region-of-interest selection and can improve the accuracy of quantitative perfusion measurements.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24901545      PMCID: PMC4184933          DOI: 10.1097/RLI.0000000000000074

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  32 in total

Review 1.  Microbubbles in medical imaging: current applications and future directions.

Authors:  Jonathan R Lindner
Journal:  Nat Rev Drug Discov       Date:  2004-06       Impact factor: 84.694

2.  Efficient subpixel image registration algorithms.

Authors:  Manuel Guizar-Sicairos; Samuel T Thurman; James R Fienup
Journal:  Opt Lett       Date:  2008-01-15       Impact factor: 3.776

3.  Quantitative mapping of tumor vascularity using volumetric contrast-enhanced ultrasound.

Authors:  Kenneth Hoyt; Anna Sorace; Reshu Saini
Journal:  Invest Radiol       Date:  2012-03       Impact factor: 6.016

4.  Assessment and monitoring tumor vascularity with contrast-enhanced ultrasound maximum intensity persistence imaging.

Authors:  Marybeth A Pysz; Kira Foygel; Cedric M Panje; Andrew Needles; Lu Tian; Jürgen K Willmann
Journal:  Invest Radiol       Date:  2011-03       Impact factor: 6.016

Review 5.  Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy.

Authors:  Rakesh K Jain
Journal:  Science       Date:  2005-01-07       Impact factor: 47.728

6.  Standardization of dynamic contrast-enhanced ultrasound for the evaluation of antiangiogenic therapies: the French multicenter Support for Innovative and Expensive Techniques Study.

Authors:  Nathalie Lassau; Louis Chapotot; Baya Benatsou; Valérie Vilgrain; Michèle Kind; Joëlle Lacroix; Marie Cuinet; Sophie Taieb; Richard Aziza; Antony Sarran; Catherine Labbe; Benoît Gallix; Olivier Lucidarme; Yvette Ptak; Laurence Rocher; Louis Michel Caquot; Sophie Chagnon; Denis Marion; Alain Luciani; Joëlle Uzan-Augui; Serge Koscielny
Journal:  Invest Radiol       Date:  2012-12       Impact factor: 6.016

7.  Automating tumor classification with pixel-by-pixel contrast-enhanced ultrasound perfusion kinetics.

Authors:  Casey N Ta; Yuko Kono; Christopher V Barback; Robert F Mattrey; Andrew C Kummel
Journal:  J Vac Sci Technol B Nanotechnol Microelectron       Date:  2012-03-22

8.  Contrast-enhanced ultrasound for detection and diagnosis of renal clear cell carcinoma.

Authors:  Xiao-qiu Dong; Yi Shen; Li-wei Xu; Chun-mei Xu; Wei Bi; Xiao-min Wang
Journal:  Chin Med J (Engl)       Date:  2009-05-20       Impact factor: 2.628

9.  Renal cell carcinoma: real-time contrast-enhanced ultrasound findings.

Authors:  Zuo-Feng Xu; Hui-Xiong Xu; Xiao-Yan Xie; Guang-Jian Liu; Yan-Ling Zheng; Jin-Yu Liang; Ming-De Lu
Journal:  Abdom Imaging       Date:  2010-12

Review 10.  Contrast-enhanced ultrasound for diagnosis of prostate cancer and kidney lesions.

Authors:  Michael Mitterberger; Alexandre Pelzer; Daniela Colleselli; Georg Bartsch; Hannes Strasser; Leo Pallwein; Friedrich Aigner; Johann Gradl; Ferdinand Frauscher
Journal:  Eur J Radiol       Date:  2007-09-18       Impact factor: 3.528

View more
  3 in total

1.  A Comprehensive Motion Compensation Method for In-Plane and Out-of-Plane Motion in Dynamic Contrast-Enhanced Ultrasound of Focal Liver Lesions.

Authors:  Thodsawit Tiyarattanachai; Simona Turco; John R Eisenbrey; Corinne E Wessner; Alexandra Medellin-Kowalewski; Stephanie Wilson; Andrej Lyshchik; Aya Kamaya; Ahmed El Kaffas
Journal:  Ultrasound Med Biol       Date:  2022-08-13       Impact factor: 3.694

2.  Focal Liver Lesions: Computer-aided Diagnosis by Using Contrast-enhanced US Cine Recordings.

Authors:  Casey N Ta; Yuko Kono; Mohammad Eghtedari; Young Taik Oh; Michelle L Robbin; Richard G Barr; Andrew C Kummel; Robert F Mattrey
Journal:  Radiology       Date:  2017-10-25       Impact factor: 11.105

3.  Super-Resolution Contrast-Enhanced Ultrasound Methodology for the Identification of In Vivo Vascular Dynamics in 2D.

Authors:  Evangelos Kanoulas; Mairead Butler; Caitlin Rowley; Vasiliki Voulgaridou; Konstantinos Diamantis; William Colin Duncan; Alan McNeilly; Michalakis Averkiou; Hessel Wijkstra; Massimo Mischi; Rhodri Simon Wilson; Weiping Lu; Vassilis Sboros
Journal:  Invest Radiol       Date:  2019-08       Impact factor: 6.016

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.